GRAIL, Inc. Common Stock (GRAL) is a publicly traded Healthcare sector company. As of November 8, 2026, GRAL trades at $122.47 with a market cap of $5.46B and a P/E ratio of -14.17. GRAL moved +1.97% today. Year to date, GRAL is +41.89%; over the trailing twelve months it is +43.48%. Its 52-week range spans $20.44 to $166.48. Analyst consensus is buy with an average price target of $128.67. Rallies surfaces GRAL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for GRAL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $122.47 |
| Market Cap | $5.46B |
| P/E Ratio | -14.17 |
| EPS | $-9.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $166.48 |
| 52-Week Low | $20.44 |
| Volume | 688.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $165.26M |
| Net Income | $-391.59M |
| Gross Margin | 0.00% |
10 analysts cover GRAL: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $128.67.